Vivos Therapeutics, Inc. (VVOS) Free cash flow 2019–2025
Vivos Therapeutics, Inc. (VVOS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$17.6MFY2025 · since FY2019: -$5.5M → -$17.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.6M | -32.8% |
| FY2024 | -$13.3M | -4.0% |
| FY2023 | -$12.7M | +37.8% |
| FY2022 | -$20.5M | -13.1% |
| FY2021 | -$18.1M | -212.6% |
| FY2020 | -$5.8M | -5.1% |
| FY2019 | -$5.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice